Kintor Pharmaceutical Limited (HKG:9939)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.220
+0.010 (0.83%)
Apr 25, 2025, 11:26 AM HKT
27.08%
Market Cap 523.89M
Revenue (ttm) 5.32M
Net Income (ttm) -165.26M
Shares Out 432.97M
EPS (ttm) -0.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 125,500
Average Volume 2,667,475
Open 1.210
Previous Close 1.210
Day's Range 1.200 - 1.230
52-Week Range 0.790 - 1.840
Beta -0.10
RSI 50.87
Earnings Date May 26, 2025

About Kintor Pharmaceutical

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in researching, developing, and commercializing therapeutic drugs for dermatology and tumors indications with the unmet medical needs in the People’s Republic of China. Its product candidates include KX-826, a potential topical drug for the treatment of androgenic alopecia and acne vulgaris; and Pruxelutamide (GT0918), a second-generation androgen receptor (AR) for the treatment of metastatic castration-resistant prostate cancer, COVID-19, and AR+ metastatic breast c... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 168
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9939
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.